Back

Effects of interleukin 6 inhibitor tocilizumab on endothelial glycocalyx, vascular and myocardial function compared to prednisolone.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Chronic inflammatory diseases Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

7 More presentations in this session

Presentation thumbnail
Coronary microvascular dysfunction in inflammatory bowel disease: Restored after enterectomy
Doctor K. Kakuta (Yokkaichi, JP)
Abstract Slides
Presentation thumbnail
Equal cardiovascular risk in patients with diabetes mellitus versus rheumatoid arthritis?
Doctor B. Logstrup (Aarhus, DK)
Abstract
Presentation thumbnail
The first report of significantly improvement of NT-proBNP level in rheumatoid arthritis patients treated with tofacitinib during 12-month follow-up.
Doctor D. Novikova (Moscow, RU)
Abstract Slides
Presentation thumbnail
Impaired myocardial healing in patients with diabetes after ST-Elevation Myocardial Infarction
Doctor M. Wamil (Oxford, GB)
Abstract Slides
Presentation thumbnail
Exercise limitation in systemic sclerosis: a case-controlled study
Doctor A. Rimouche (Brussels, BE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Chronic inflammatory diseases

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources